Biomarkers

News

ESMO guidance on the validation and clinical use of AI-based biomarkers in oncology aims to strike a balance between caution and over-reliance.

News

Procyon is hoping to launch a diagnostic test next year that will be able to detect people at risk of pancreatic cancer from a urine sample.

Digital

A close examination of the current and future role of AI in biomarker discovery and the challenges that developers face in leveraging it.

R&D

What makes a biomarker a biomarker?

Partner Content

The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies

R&D

As public funding becomes more uncertain, lab and clinical services professionals are increasingly being called on to help.